Silence Therapeutics (United Kingdom)

Silence Therapeutics (United Kingdom)

Silence Therapeutics, is a London-based pharmaceutical company formed in 1994. The company since its inception has pioneered the design and development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Silence Therapeutics (United Kingdom), United Kingdom, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

57%


Total
Publications

96


Total Open
Publications

55


Total
Citations

2.2K


Open Access
Percentage

57%


Total
Publications

96


Total Open
Publications

55


Total
Citations

2.2K

Wikipedia

Website

download

Breakdown

15% 38% 4% 43%

Publisher Open

15%

Both

38%

Other Platform Open

4%

Closed

43%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

33%OA Journal

OA Journal 33%

17

Hybrid 35%

18

No Guarantees 32%

16

Other Platform Open

Domain 80%

33

Institution 44%

18

Preprint 12%

5

Other Internet 12%

5

Public 10%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
33
Europe PMC
Domain
18
Figshare
Public
13
bioRxiv
Preprint
4
University of East Anglia - UEA Digital Repository
Institution
3
Unknown Repository
Other Internet
2
University of the Basque Country - Communities in ADDI
Institution
2
University of Edinburgh - Edinburgh Research Explorer
Institution
2
University of Bristol - Bristol Research
Institution
2
University College London - UCL Discovery
Institution
2
1 / 3

Data updated 25 January 2024

Share

Share

Share